RXO, Inc. (NYSE:RXO) Receives Consensus Rating of “Hold” from Analysts

RXO, Inc. (NYSE:RXOGet Free Report) has been assigned an average recommendation of “Hold” from the fourteen brokerages that are presently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation and three have given a buy recommendation to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $25.67.

Several analysts recently commented on the stock. JPMorgan Chase & Co. raised their price target on shares of RXO from $25.00 to $26.00 and gave the stock an “underweight” rating in a report on Thursday, August 8th. Susquehanna decreased their price target on shares of RXO from $20.00 to $16.00 and set a “negative” rating for the company in a report on Thursday, September 26th. Morgan Stanley raised their price target on shares of RXO from $19.00 to $26.00 and gave the stock an “equal weight” rating in a report on Monday, August 12th. TD Cowen raised their price target on shares of RXO from $23.00 to $28.00 and gave the stock a “hold” rating in a report on Thursday, August 8th. Finally, Jefferies Financial Group decreased their price target on shares of RXO from $33.00 to $31.00 and set a “buy” rating for the company in a report on Tuesday, August 13th.

Read Our Latest Analysis on RXO

RXO Stock Performance

Shares of RXO opened at $27.06 on Friday. The firm’s 50 day moving average is $28.21 and its 200-day moving average is $24.30. The stock has a market capitalization of $3.18 billion, a P/E ratio of -300.67, a P/E/G ratio of 13.43 and a beta of 1.34. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.17 and a quick ratio of 1.17. RXO has a 12-month low of $16.94 and a 12-month high of $32.82.

RXO (NYSE:RXOGet Free Report) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.03 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.03. The company had revenue of $930.00 million for the quarter, compared to analysts’ expectations of $934.14 million. RXO had a negative net margin of 0.55% and a positive return on equity of 2.22%. The business’s revenue was down 3.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.08 EPS. Equities research analysts anticipate that RXO will post 0.14 EPS for the current fiscal year.

Institutional Trading of RXO

Large investors have recently modified their holdings of the company. Dimensional Fund Advisors LP boosted its holdings in shares of RXO by 5.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,869,583 shares of the company’s stock worth $43,489,000 after buying an additional 93,885 shares during the period. Douglas Lane & Associates LLC boosted its holdings in shares of RXO by 2.6% during the 1st quarter. Douglas Lane & Associates LLC now owns 2,646,147 shares of the company’s stock worth $57,871,000 after buying an additional 66,757 shares during the period. Norges Bank bought a new stake in shares of RXO during the 4th quarter worth $24,250,000. GSA Capital Partners LLP boosted its holdings in shares of RXO by 433.8% during the 1st quarter. GSA Capital Partners LLP now owns 56,002 shares of the company’s stock worth $1,225,000 after buying an additional 45,510 shares during the period. Finally, UniSuper Management Pty Ltd bought a new stake in shares of RXO during the 1st quarter worth $542,000. 92.73% of the stock is owned by institutional investors.

About RXO

(Get Free Report

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Featured Articles

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.